Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
LC Tao, J Xu, T Wang, F Hua, JJ Li - Cardiovascular diabetology, 2022 - Springer
The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker
of insulin resistance (IR). Recently, a considerable number of studies have provided robust …
of insulin resistance (IR). Recently, a considerable number of studies have provided robust …
Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies
Objective To present a comprehensive review of the association between measures of body
weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes …
weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes …
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE …
P Lopez-Jaramillo, D Gomez-Arbelaez… - The Lancet Healthy …, 2023 - thelancet.com
Summary Background The triglyceride glucose (TyG) index is an easily accessible surrogate
marker of insulin resistance, an important pathway in the development of type 2 diabetes …
marker of insulin resistance, an important pathway in the development of type 2 diabetes …
Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
L Wang, H Cong, J Zhang, Y Hu, A Wei… - Cardiovascular …, 2020 - Springer
Background The triglyceride-glucose index (TyG index) has been regarded as a reliable
alternative marker of insulin resistance and an independent predictor of cardiovascular …
alternative marker of insulin resistance and an independent predictor of cardiovascular …
The TyG index may predict the development of cardiovascular events
L Sánchez‐Íñigo, D Navarro‐González… - European journal of …, 2016 - Wiley Online Library
Background Cardiovascular disease (CVD) is the worldwide leading cause of morbidity and
mortality. An early risk detection of apparently healthy people before CVD onset has clinical …
mortality. An early risk detection of apparently healthy people before CVD onset has clinical …
The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
Background To investigate whether the Triglyceride-Glucose index (TyG-index) is
associated with increased risk of cardiovascular diseases (CVD)/coronary heart disease …
associated with increased risk of cardiovascular diseases (CVD)/coronary heart disease …
The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic …
Aims Insulin resistance is an independent risk factor for developing type 2 diabetes.
Therefore, this study compared the predictability of the triglyceride–glucose (TyG) index and …
Therefore, this study compared the predictability of the triglyceride–glucose (TyG) index and …
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
L Fedchuk, F Nascimbeni, R Pais… - Alimentary …, 2014 - Wiley Online Library
Background Several steatosis biomarkers are available with limited independent validation.
Aim To determine diagnostic value and limitations of several steatosis biomarkers using liver …
Aim To determine diagnostic value and limitations of several steatosis biomarkers using liver …
METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes
OY Bello-Chavolla, P Almeda-Valdes… - European journal of …, 2018 - academic.oup.com
Objective We developed a novel non-insulin-based fasting score to evaluate insulin
sensitivity validated against the euglycemic–hyperinsulinemic clamp (EHC). We also …
sensitivity validated against the euglycemic–hyperinsulinemic clamp (EHC). We also …
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
B Richter, B Hemmingsen… - Cochrane Database …, 2018 - cochranelibrary.com
Background Intermediate hyperglycaemia (IH) is characterised by one or more
measurements of elevated blood glucose concentrations, such as impaired fasting glucose …
measurements of elevated blood glucose concentrations, such as impaired fasting glucose …